KarenLKellyMD

PubMed

• CNS Antitumor Activity of Amivantamab With Osimertinib in Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer With Acquired Mesenchymal-Epithelial Tran...
  Ebaa Al-Obeidi, Karen Kelly, David R Gandara, Jonathan W Riess> ;JCO Precision Oncology. 2024 Apr 1
• Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial.
  Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, Edgar Gonzalez-Kozlova, Mary W Redman, Hong Chen, Ganiraju C Manyam, Gayatri Kumar, Jianhua Zhang, Xingzhi Song, Ros...> ;Clinical Cancer Research. 2024 Apr 15
• Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP).
  Riha Vaidya, Joseph M Unger, Lu Qian, Katherine Minichiello, Roy S Herbst, David R Gandara, Joel W Neal, Ticiana A Leal, Jyoti D Patel, Konstantin H Dragnev, Saiama N ...> ;JCO Precision Oncology. 2023 Sep 1
• 1 citations
  The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative.
  Stephen Lam, Murry W Wynes, Casey Connolly, Kazuto Ashizawa, Sukhinder Atkar-Khattra, Chandra P Belani, Domenic DiNatale, Claudia I Henschke, Bruno Hochhegger, Claudio...> ;Journal of Thoracic Oncology. 2024 Jan 1
• 3 citations
  International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy.
  Sanja Dacic, William Travis, Mary Redman, Anjali Saqi, Wendy A Cooper, Alain Borczuk, Jin-Haeng Chung, Carolyn Glass, Javier Martin Lopez, Anja C Roden, Lynette Sholl,...> ;Journal of Thoracic Oncology. 2023 Oct 1
• 1 citations
  Phase II Study of Docetaxel and Trametinib in Patients with KRAS Mutation Positive Recurrent Non-Small Cell Lung Cancer (NSCLC; SWOG S1507, NCT-02642042).
  Shirish M Gadgeel, Jieling Miao, Jonathan W Riess, James Moon, Philip C Mack, Gregory J Gerstner, Timothy F Burns, Asma Taj, Wallace L Akerley, Konstantin H Dragnev, N...> ;Clinical Cancer Research. 2023 Sep 15
• 2 citations
  Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I.
  Joseph M Unger, Lu Qian, Mary W Redman, Susan S Tavernier, Lori Minasian, Ellen V Sigal, Vassiliki A Papadimitrakopoulou, Michael Leblanc, Charles S Cleeland, Samuel A...> ;Journal of the National Cancer Institute. 2023 Apr 11
• 3 citations
  Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced gliob...
  Benedito A Carneiro, Kyriakos P Papadopoulos, John H Strickler, Andrew B Lassman, Saiama N Waqar, Young Kwang Chae, Jyoti D Patel, Einat Shacham-Shmueli, Karen Kelly, ...> ;Neuro-Oncology Advances. 2022 Dec 21
• 6 citations
  The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study.
  David J Benjamin, Shuai Chen, Joanna B Eldredge, Shiruyeh Schokrpur, Debory Li, Zhikuan Quan, Jason W Chan, Amy L Cummings, Megan E Daly, Jonathan W Goldman, Matthew A...> ;JTO Clinical and Research Reports. 2022 Dec 1
• 14 citations
  Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
  D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, Daniel Morgensztern, Rebecca Heist, Everett Vokes, Alex Spira, Eric Angevin, Wu-Chou Su, David S Hong, John H Stri...> ;Journal of Clinical Oncology. 2023 Feb 10
• 4 citations
  A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
  Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, Ai-Ming Yu, Karen Matsukuma, Thomas J Semrad, David R Gandara, Tianhong Li, Jonathan W Riess, Kit Tam, Philip C Mack, Antho...> ;Cancer Chemotherapy and Pharmacology. 2022 Sep 1
• 12 citations
  Circulating Tumor DNA Kinetics Predict Progression-Free and Overall Survival in EGFR TKI-Treated Patients with EGFR-Mutant NSCLC (SWOG S1403).
  Philip C Mack, Jieling Miao, Mary W Redman, James Moon, Sarah B Goldberg, Roy S Herbst, Mary Ann Melnick, Zenta Walther, Fred R Hirsch, Katerina Politi, Karen Kelly, D...> ;Clinical Cancer Research. 2022 Sep 1
• 62 citations
  Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non-Small-Cell Lung Cancer Previously Treated With Immunotherapy-Lung-MA...
  Karen L Reckamp, Mary W Redman, Konstantin H Dragnev, Katherine Minichiello, Liza C Villaruz, Bryan Faller, Tareq Al Baghdadi, Susan Hines, Leah Everhart, Louise Highl...> ;Journal of Clinical Oncology. 2022 Jul 20
• 3 citations
  International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials.
  Matthew P Smeltzer, Giorgio V Scagliotti, Heather A Wakelee, Tetsuya Mitsudomi, Upal Basu Roy, Russell C Clark, Renee Arndt, Clayton D Pruett, Karen L Kelly, Peter Ujh...> ;Journal of Thoracic Oncology. 2022 May 1
• 25 citations
  Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216).
  Kenneth L Kehl, David Zahrieh, Ping Yang, Shauna L Hillman, Angelina D Tan, Jacob M Sands, Geoffrey R Oxnard, Erin A Gillaspie, Dennis Wigle, Shakun Malik, Thomas E St...> ;JAMA Oncology. 2022 May 1
• 1 citations
  Long-term avelumab in advanced non-small-cell lung cancer: summaries andanalyses from JAVELIN Solid Tumor.
  Borys Hrinczenko, Nicholas Iannotti, Sanjay Goel, David Spigel, Howard Safran, Matthew H Taylor, Jaafar Bennouna, Deborah J Wong, Karen Kelly, Claire Verschraegen, Mar...> ;Future Oncology. 2022 Apr 1
• 5 citations
  Phase I pharmacokinetic study of single agent trametinib in patients with advanced cancer and hepatic dysfunction.
  Pei Jye Voon, Eric X Chen, Helen X Chen, Albert C Lockhart, Solmaz Sahebjam, Karen Kelly, Ulka N Vaishampayan, Vivek Subbiah, Albiruni R Razak, Daniel J Renouf, Sebast...> ;Journal of Experimental & Clinical Cancer Research. 2022 Feb 7
• 7 citations
  A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC.
  D Ross Camidge, Fabrice Barlesi, Jonathan W Goldman, Daniel Morgensztern, Rebecca Heist, Everett Vokes, Eric Angevin, David S Hong, Igor I Rybkin, Minal Barve, Todd M ...> ;JTO Clinical and Research Reports. 2022 Jan 1
• 5 citations
  EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG...
  Fred R. Hirsch, Mary W. Redman, James Moon, Francesco Agustoni, Roy S. Herbst, Thomas J. Semrad, Marileila Varella-Garcia, Christopher J. Rivard, Karen Kelly, David R....> ;Clinical Lung Cancer. 2021 Oct 10
• 21 citations
  Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody–Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non–Small Cell Lung Ca...
  D. Ross Camidge, Daniel Morgensztern, Rebecca S. Heist, Minal A. Barve, Everett E. Vokes, Jonathan W. Goldman, David S. Hong, Todd M. Bauer, John H. Strickler, Eric An...> ;Clinical Cancer Research. 2021 Aug 23
• 23 citations
  Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP s...
  Natasha B. Leighl, Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz, James L. Wade, William J. Irvin, Sreekanth Reddy, Jeffrey Cra...> ;Journal for Immunotherapy of Cancer. 2021 Aug 1
• 49 citations
  Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial.
  Scott N. Gettinger, Mary W. Redman, Lyudmila Bazhenova, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz, Jeffrey D. Bradley, Thomas E. Stinchcombe, Natasha B. Lei...> ;JAMA Oncology. 2021 Sep 1
• 21 citations
  Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Esophageal Adenocarcinoma: Results from a Phase 1 Cohort
  Benjamin Tan, Adnan Khattak, Enriqueta Felip, Karen Kelly, Patricia Rich, Ding Wang, Christoph Helwig, Isabelle Dussault, Laureen S. Ojalvo, Nicolas Isambert> ;Targeted Oncology. 2021 May 19
• 7 citations
  Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors
  Thomas J. Semrad, Edward J. Kim, I-Yeh Gong, Tianhong Li, Scott D Christensen, Mili Arora, Jonathan W. Riess, David R. Gandara, Karen Kelly> ;Cancer Chemotherapy and Pharmacology. 2021 May 15
• 3 citations
  Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN).
  Joshua A. Roth, Meghna S. Trivedi, Stacy W. Gray, Donald L. Patrick, Deborah M Delaney, Kate Watabayashi, Paul Litwin, Parth D. Shah, Katherine D. Crew, Monica Yee, Ma...> ;JCO Oncology Practice. 2021 Apr 2
• Join now to see all

Journal Articles

• Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade  
  R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature
• Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase 1b Study  
  Karen Kelly, Montaser Shaheen, Shadia Jalal, Daruka Mahadevan, Clinical Cancer Research

Lectures

• American Society for Radiation Oncology(ASTRO): 20th Chicago Multidisciplinary Symposium inThoracic Oncology 
  American Society for Radiation Oncology, Chicago, Illinois - 9/6/2012
• Great Debates and Updates In Thoracic Malignancies 
  Imedex, San Francisco, California - 5/5/2012